Dr. Reddy’s Laboratories Ltd. ADR (NYSE:RDY) does about 2.11M shares in volume on a normal day but saw 1407445 shares change hands in the recent trading day. The company now has a market cap of 12.97B USD. Its current market price is $15.59, marking an increase of 1.83% compared to the previous close of $15.31. The 52 week high reached by this stock is $16.89 whilst the lowest price level in 52 weeks is $12.26.
The consensus objective for the share price is $14.76, suggesting that the stock has a potential downside of -5.62% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on June 05, 2025 when HSBC Securities upgraded the stock to “Buy” and issued a price target of $16.90.
The current price level is 1.99%, 8.01%, and 7.53% away from its SMA20, SMA50, and SMA200 respectively, with the RDY price moving above the 50-day SMA on current market day. Dr. Reddy’s Laboratories Ltd. ADR (RDY) stock is down -0.83% over the week and 9.17% over the past month. Its price is 10.16% year-to-date and -1.27% over the past year.
To reach the target analysts have set, the stock logically needs to shrink -5.62 percent from here.
Outstanding shares total 834.46M with insiders holding 0.00% of the shares and institutional holders owning 13.85% of the company’s common stock. The company has a return on investment of 16.71% and return on equity of 18.36%. The price to earnings ratio (P/E ratio) amounts to 19.47 while the forward price to earnings ratio is 24.11. The beta has a value of 0.33. Price to book ratio is 3.34 and price to sales ratio is 3.37.
